Telmisartan/ja: Difference between revisions

Telmisartan/ja
Created page with "<!-- Clinical data --> | pronounce = {{IPAc-en|t|ɛ|l|m|ɪ|ˈ|s|ɑr|t|ən}} | tradename = ミカルディス, アクタビス, その他 | Drugs.com = {{drugs.com|monograph|telmisartan}} | MedlinePlus = a601249 | DailyMedID = Telmisartan | pregnancy_AU = D | routes_of_administration = By mouth | class = Angiotensin II receptor antagonist/ja | ATC_prefix = C09 | ATC_suffix = CA07"
Tags: Mobile edit Mobile web edit
 
Created page with "テルミサルタン"
Tags: Mobile edit Mobile web edit
Line 26: Line 26:
| legal_EU = RX-only
| legal_EU = RX-only


<div lang="en" dir="ltr" class="mw-content-ltr">
<!-- Pharmacokinetic data -->
<!-- Pharmacokinetic data -->
| bioavailability = 42–100%
| bioavailability = 42–100%
| protein_bound = >99.5%
| protein_bound = >99.5%
| metabolism = Minimal liver ([[glucuronidation]])
| metabolism = 最小限の肝臓([[glucuronidation/ja|グルクロン酸化]]
| elimination_half-life = 24 hours
| elimination_half-life = 24時間
| excretion = Feces 97%
| excretion = 糞中97%
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">